85 related articles for article (PubMed ID: 12569357)
1. An unusual H-Ras mutant isolated from a human multiple myeloma line leads to transformation and factor-independent cell growth.
Crowder C; Kopantzev E; Williams K; Lengel C; Miki T; Rudikoff S
Oncogene; 2003 Feb; 22(5):649-59. PubMed ID: 12569357
[TBL] [Abstract][Full Text] [Related]
2. Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.
Billadeau D; Liu P; Jelinek D; Shah N; LeBien TW; Van Ness B
Cancer Res; 1997 Jun; 57(11):2268-75. PubMed ID: 9187131
[TBL] [Abstract][Full Text] [Related]
3. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.
Billadeau D; Jelinek DF; Shah N; LeBien TW; Van Ness B
Cancer Res; 1995 Aug; 55(16):3640-6. PubMed ID: 7627974
[TBL] [Abstract][Full Text] [Related]
4. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts.
Bossù P; Vanoni M; Wanke V; Cesaroni MP; Tropea F; Melillo G; Asti C; Porzio S; Ruggiero P; Di Cioccio V; Maurizi G; Ciabini A; Alberghina L
Oncogene; 2000 Apr; 19(17):2147-54. PubMed ID: 10815806
[TBL] [Abstract][Full Text] [Related]
5. Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis.
Ward KR; Zhang KX; Somasiri AM; Roskelley CD; Schrader JW
Oncogene; 2004 Feb; 23(6):1187-96. PubMed ID: 14961075
[TBL] [Abstract][Full Text] [Related]
6. Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras.
Guo X; Schrader KA; Xu Y; Schrader JW
Oncogene; 2005 Mar; 24(14):2330-42. PubMed ID: 15735740
[TBL] [Abstract][Full Text] [Related]
7. Single-molecule diffusion measurements of H-Ras at the plasma membrane of live cells reveal microdomain localization upon activation.
Lommerse PH; Snaar-Jagalska BE; Spaink HP; Schmidt T
J Cell Sci; 2005 May; 118(Pt 9):1799-809. PubMed ID: 15860728
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
[TBL] [Abstract][Full Text] [Related]
9. Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.
Chen SC; Redenius D; Young JC; Schwartz RC
Oncogene; 1993 Aug; 8(8):2119-25. PubMed ID: 8336938
[TBL] [Abstract][Full Text] [Related]
10. Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: implications for disease progression and therapeutic response.
Rowley M; Van Ness B
Oncogene; 2002 Dec; 21(57):8769-75. PubMed ID: 12483530
[TBL] [Abstract][Full Text] [Related]
11. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
Martín P; Santón A; García-Cosío M; Bellas C
Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
[TBL] [Abstract][Full Text] [Related]
12. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
Zhang KX; Ward KR; Schrader JW
Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
[TBL] [Abstract][Full Text] [Related]
13. The isolated catalytic hairpin of the Ras-specific guanine nucleotide exchange factor Cdc25Mm retains nucleotide dissociation activity but has impaired nucleotide exchange activity.
Sacco E; Fantinato S; Manzoni R; Metalli D; De Gioia L; Fantucci P; Alberghina L; Vanoni M
FEBS Lett; 2005 Dec; 579(30):6851-8. PubMed ID: 16325815
[TBL] [Abstract][Full Text] [Related]
14. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
15. Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations.
Al-Mulla F; MacKenzie EM
J Pathol; 2001 Dec; 195(5):549-56. PubMed ID: 11745690
[TBL] [Abstract][Full Text] [Related]
16. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
17. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
18. Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer.
Yang G; Thompson JA; Fang B; Liu J
Oncogene; 2003 Aug; 22(36):5694-701. PubMed ID: 12944918
[TBL] [Abstract][Full Text] [Related]
19. The hemopoietic progenitor 32DCl3(G) cells synthesize C3 molecules and acquire C3b acceptor sites upon differentiation or neoplastic transformation.
Di Renzo L; Zicari A; Longo A; Realacci M; Naso G; Pontieri G; Lipari M
J Immunol; 1993 Oct; 151(7):3737-45. PubMed ID: 8376803
[TBL] [Abstract][Full Text] [Related]
20. Influencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42.
Fidyk N; Wang JB; Cerione RA
Biochemistry; 2006 Jun; 45(25):7750-62. PubMed ID: 16784226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
